StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Valeant Pharma (VRX) CEO said his best estimate is 10-K will be filed in April - Bloomberg
March 15, 2016 9:48 AM
Valeant Pharma (NYSE: VRX) ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Short Sales
Trader Talk
Next Articles
Deutsche Bank Comments on Valeant Pharma (VRX) Following Q4 Call
March 15, 2016 2:20 PM
UPDATE: Piper Jaffray Downgrades Valeant Pharmaceuticals (VRX) to Underweight
March 15, 2016 11:15 AM
Valeant Pharma (VRX) Results Suggest Disruption in the Business - Evecore ISI's Raffat
March 15, 2016 10:56 AM
Valeant Pharma (VRX) Conference Call Ends
March 15, 2016 10:13 AM
The Single Most Important Catalyst for Valeant Pharma (VRX) Near-Term...
March 15, 2016 8:15 AM